Correlation Between Eliem Therapeutics and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Dyadic International, you can compare the effects of market volatilities on Eliem Therapeutics and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Dyadic International.
Diversification Opportunities for Eliem Therapeutics and Dyadic International
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eliem and Dyadic is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Dyadic International go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Dyadic International
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.44 times less risky than Dyadic International. The stock trades about -0.29 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 109.00 in Dyadic International on August 29, 2024 and sell it today you would earn a total of 64.00 from holding Dyadic International or generate 58.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Eliem Therapeutics vs. Dyadic International
Performance |
| Timeline |
| Eliem Therapeutics |
| Dyadic International |
Eliem Therapeutics and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Dyadic International
The main advantage of trading using opposite Eliem Therapeutics and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Dyadic International vs. Eliem Therapeutics | Dyadic International vs. Scpharmaceuticals | Dyadic International vs. Milestone Pharmaceuticals | Dyadic International vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |